{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:51:12Z","timestamp":1790351472647,"version":"4.1.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Extracellular vesicles (EVs) are lipid bilayer-enclosed particles released by cells into the extracellular space. They are produced by the majority of cell types under both physiological and pathological conditions. EVs mediate intercellular communication by delivering bioactive molecules - such as RNAs, adhesion molecules, signaling mediators, and antigen-presenting molecules - to recipient cells, thereby modulating their phenotype and function. A growing body of evidence highlights the involvement of EVs in the pathophysiology of leukemia, including their roles in remodeling the bone marrow microenvironment, promoting angiogenesis, enabling immune evasion, regulating apoptosis, and contributing to drug resistance. Beyond their functional roles, EVs are emerging as promising diagnostic and prognostic biomarkers, as well as potential drug delivery vehicles. This review first outlines key aspects of chronic myeloid leukemia and the bone marrow niche, and then focuses on the current understanding of how EVs contribute to the transformation of a normal bone marrow environment into a leukemic one. Finally, we discuss the potential applications of EVs as biomarkers and therapeutic delivery systems in chronic myeloid leukemia.<\/jats:p>","DOI":"10.1007\/s13105-026-01184-0","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:58:40Z","timestamp":1776416320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Roles of extracellular vesicles in the pathogenesis of chronic myeloid leukemia"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4773-4581","authenticated-orcid":false,"given":"Tereza","family":"Hrdinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-5018","authenticated-orcid":false,"given":"Helena","family":"Kupcova Skalnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01630378","volume":"8","author":"PC Nowell","year":"1962","unstructured":"Nowell PC (1962) The minute chromosome (Phl) in chronic granulocytic leukemia. Blut 8:65\u201366. https:\/\/doi.org\/10.1007\/BF01630378","journal-title":"Blut"},{"issue":"5405","key":"1184_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243(5405):290\u2013293. https:\/\/doi.org\/10.1038\/243290a0","journal-title":"Nature"},{"issue":"5940","key":"1184_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/306239a0","volume":"306","author":"N Heisterkamp","year":"1983","unstructured":"Heisterkamp N, Stephenson JR, Groffen J et al (1983) Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306(5940):239\u2013242. https:\/\/doi.org\/10.1038\/306239a0","journal-title":"Nature"},{"issue":"1","key":"1184_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36(1):93\u201399. https:\/\/doi.org\/10.1016\/0092-8674(84)90077-1","journal-title":"Cell"},{"issue":"6128","key":"1184_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/328342a0","volume":"328","author":"MY Gordon","year":"1987","unstructured":"Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF (1987) Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328(6128):342\u2013344. https:\/\/doi.org\/10.1038\/328342a0","journal-title":"Nature"},{"issue":"4","key":"1184_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","volume":"13","author":"L Puil","year":"1994","unstructured":"Puil L, Liu J, Gish G et al (1994) Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 13(4):764\u2013773","journal-title":"EMBO J"},{"issue":"8","key":"1184_CR7","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","volume":"83","author":"A Bedi","year":"1994","unstructured":"Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83(8):2038\u20132044","journal-title":"Blood"},{"issue":"18","key":"1184_CR8","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/sj.onc.1201049","volume":"14","author":"SK Jain","year":"1997","unstructured":"Jain SK, Langdon WY, Varticovski L (1997) Tyrosine phosphorylation of p120cbl in BCR\/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Oncogene 14(18):2217\u20132228. https:\/\/doi.org\/10.1038\/sj.onc.1201049","journal-title":"Oncogene"},{"issue":"49","key":"1184_CR9","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","volume":"271","author":"RLJ Ilaria","year":"1996","unstructured":"Ilaria RLJ, Van Etten RA (1996) P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 271(49):31704\u201331710. https:\/\/doi.org\/10.1074\/jbc.271.49.31704","journal-title":"J Biol Chem"},{"issue":"4","key":"1184_CR10","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","volume":"105","author":"JH Kim","year":"2005","unstructured":"Kim JH, Chu SC, Gramlich JL et al (2005) Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 105(4):1717\u20131723. https:\/\/doi.org\/10.1182\/blood-2004-03-0849","journal-title":"Blood"},{"key":"1184_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246141","author":"L Bavaro","year":"2019","unstructured":"Bavaro L, Martelli M, Cavo M, Soverini S (2019) Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20246141","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1184_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/sj.leu.2402577","volume":"16","author":"AS Shet","year":"2002","unstructured":"Shet AS, Jahagirdar BN, Verfaillie CM (2002) Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia 16(8):1402\u20131411. https:\/\/doi.org\/10.1038\/sj.leu.2402577","journal-title":"Leukemia"},{"issue":"3","key":"1184_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0002-9343(87)90754-6","volume":"83","author":"HM Kantarjian","year":"1987","unstructured":"Kantarjian HM, Keating MJ, Talpaz M et al (1987) Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 83(3):445\u2013454. https:\/\/doi.org\/10.1016\/0002-9343(87)90754-6","journal-title":"Am J Med"},{"issue":"5","key":"1184_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E et al (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2(5):561\u2013566. https:\/\/doi.org\/10.1038\/nm0596-561","journal-title":"Nat Med"},{"issue":"1","key":"1184_CR15","first-page":"100","volume":"56","author":"E Buchdunger","year":"1996","unstructured":"Buchdunger E, Zimmermann J, Mett H et al (1996) Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56(1):100\u2013104","journal-title":"Cancer Res"},{"issue":"9","key":"1184_CR16","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood.V90.9.3691","volume":"90","author":"MW Deininger","year":"1997","unstructured":"Deininger MW, Goldman JM, Lydon N, Melo JV (1997) The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood 90(9):3691\u20133698","journal-title":"Blood"},{"issue":"2","key":"1184_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/107327480901600204","volume":"16","author":"A Quint\u00e1s-Cardama","year":"2009","unstructured":"Quint\u00e1s-Cardama A, Kantarjian HM, Cortes JE (2009) Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia. Cancer Control 16(2):122\u2013131. https:\/\/doi.org\/10.1177\/107327480901600204","journal-title":"Cancer Control"},{"issue":"5531","key":"1184_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K et al (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293(5531):876\u2013880. https:\/\/doi.org\/10.1126\/science.1062538","journal-title":"Science"},{"issue":"11","key":"1184_CR19","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","volume":"16","author":"A Hochhaus","year":"2002","unstructured":"Hochhaus A, Kreil S, Corbin AS et al (2002) Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 16(11):2190\u20132196. https:\/\/doi.org\/10.1038\/sj.leu.2402741","journal-title":"Leukemia"},{"issue":"1","key":"1184_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.v99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, J\u00f8rgensen HG, Allan E et al (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99(1):319\u2013325. https:\/\/doi.org\/10.1182\/blood.v99.1.319","journal-title":"Blood"},{"issue":"6","key":"1184_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","volume":"23","author":"A Giustacchini","year":"2017","unstructured":"Giustacchini A, Thongjuea S, Barkas N et al (2017) Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia. Nat Med 23(6):692\u2013702. https:\/\/doi.org\/10.1038\/nm.4336","journal-title":"Nat Med"},{"issue":"12","key":"1184_CR22","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/leu.2015.196","volume":"29","author":"AM Eiring","year":"2015","unstructured":"Eiring AM, Khorashad JS, Anderson DJ et al (2015) \u03b2-catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. Leukemia 29(12):2328\u20132337. https:\/\/doi.org\/10.1038\/leu.2015.196","journal-title":"Leukemia"},{"issue":"4","key":"1184_CR23","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1002\/jcp.27142","volume":"234","author":"N Jafarzadeh","year":"2019","unstructured":"Jafarzadeh N, Safari Z, Pornour M, Amirizadeh N, Forouzandeh Moghadam M, Sadeghizadeh M (2019) Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes. J Cell Physiol 234(4):3697\u20133710. https:\/\/doi.org\/10.1002\/jcp.27142","journal-title":"J Cell Physiol"},{"issue":"1","key":"1184_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08734-3","volume":"21","author":"N Jafarzadeh","year":"2021","unstructured":"Jafarzadeh N, Gholampour MA, Alivand M-R et al (2021) CML derived exosomes promote tumor favorable functional performance in T cells. BMC Cancer 21(1):1002. https:\/\/doi.org\/10.1186\/s12885-021-08734-3","journal-title":"BMC Cancer"},{"issue":"2","key":"1184_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.yexcr.2017.12.001","volume":"362","author":"Q-H Min","year":"2018","unstructured":"Min Q-H, Wang X-Z, Zhang J et al (2018) Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365. Exp Cell Res 362(2):386\u2013393. https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.001","journal-title":"Exp Cell Res"},{"issue":"1","key":"1184_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10373-3","volume":"7","author":"A Kumar","year":"2017","unstructured":"Kumar A, Bhattacharyya J, Jaganathan BG (2017) Adhesion to stromal cells mediates imatinib resistance in chronic myeloid leukemia through ERK and BMP signaling pathways. Sci Rep 7(1):9535. https:\/\/doi.org\/10.1038\/s41598-017-10373-3","journal-title":"Sci Rep"},{"key":"1184_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. https:\/\/doi.org\/10.3390\/cells8070727","journal-title":"Cells"},{"key":"1184_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00738","author":"E Willms","year":"2018","unstructured":"Willms E, Caba\u00f1as C, M\u00e4ger I, Wood MJA, Vader P (2018) Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00738","journal-title":"Front Immunol"},{"issue":"1","key":"1184_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"1184_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1083\/jcb.97.2.329","volume":"97","author":"C Harding","year":"1983","unstructured":"Harding C, Heuser J, Stahl P (1983) Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97(2):329\u2013339. https:\/\/doi.org\/10.1083\/jcb.97.2.329","journal-title":"J Cell Biol"},{"issue":"3","key":"1184_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1083\/jcb.101.3.942","volume":"101","author":"BT Pan","year":"1985","unstructured":"Pan BT, Teng K, Wu C, Adam M, Johnstone RM (1985) Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 101(3):942\u2013948. https:\/\/doi.org\/10.1083\/jcb.101.3.942","journal-title":"J Cell Biol"},{"issue":"19","key":"1184_CR32","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262(19):9412\u20139420","journal-title":"J Biol Chem"},{"issue":"1","key":"1184_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 19(1):47. https:\/\/doi.org\/10.1186\/s12964-021-00730-1","journal-title":"Cell Commun Signal"},{"issue":"2","key":"1184_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tcb.2008.11.003","volume":"19","author":"E Cocucci","year":"2009","unstructured":"Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19(2):43\u201351. https:\/\/doi.org\/10.1016\/j.tcb.2008.11.003","journal-title":"Trends Cell Biol"},{"key":"1184_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biology9010021","author":"M Battistelli","year":"2020","unstructured":"Battistelli M, Falcieri E (2020) Apoptotic bodies: particular extracellular vesicles involved in intercellular communication. Biology. https:\/\/doi.org\/10.3390\/biology9010021","journal-title":"Biology"},{"issue":"2","key":"1184_CR36","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles 13(2):e12404. https:\/\/doi.org\/10.1002\/jev2.12404","journal-title":"J Extracell Vesicles"},{"issue":"12","key":"1184_CR37","doi-asserted-by":"publisher","first-page":"7309","DOI":"10.4049\/jimmunol.166.12.7309","volume":"166","author":"C Th\u00e9ry","year":"2001","unstructured":"Th\u00e9ry C, Boussac M, V\u00e9ron P et al (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166(12):7309\u20137318. https:\/\/doi.org\/10.4049\/jimmunol.166.12.7309","journal-title":"J Immunol"},{"issue":"6","key":"1184_CR38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"issue":"7","key":"1184_CR39","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Melo SA, Protopopov A et al (2014) Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289(7):3869\u20133875. https:\/\/doi.org\/10.1074\/jbc.C113.532267","journal-title":"J Biol Chem"},{"issue":"7","key":"1184_CR40","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.bbalip.2013.04.011","volume":"1831","author":"A Llorente","year":"2013","unstructured":"Llorente A, Skotland T, Sylv\u00e4nne T et al (2013) Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta 1831(7):1302\u20131309. https:\/\/doi.org\/10.1016\/j.bbalip.2013.04.011","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1184_CR41","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/cr.2014.44","volume":"24","author":"BK Thakur","year":"2014","unstructured":"Thakur BK, Zhang H, Becker A et al (2014) Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24(6):766\u2013769. https:\/\/doi.org\/10.1038\/cr.2014.44","journal-title":"Cell Res"},{"issue":"12","key":"1184_CR42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J, W\u00fcrdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470\u20131476. https:\/\/doi.org\/10.1038\/ncb1800","journal-title":"Nat Cell Biol"},{"key":"1184_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1505403","author":"T Vagner","year":"2018","unstructured":"Vagner T, Spinelli C, Minciacchi VR et al (2018) Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. J Extracell Vesicles. https:\/\/doi.org\/10.1080\/20013078.2018.1505403","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"1184_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3892\/mmr.2019.10340","volume":"20","author":"D Ko\u0142at","year":"2019","unstructured":"Ko\u0142at D, Hammouz R, Bednarek AK, P\u0142uciennik E (2019) Exosomes as carriers transporting long non-coding RNAs: Molecular characteristics and their function in cancer (Review). Mol Med Rep 20(2):851\u2013862. https:\/\/doi.org\/10.3892\/mmr.2019.10340","journal-title":"Mol Med Rep"},{"key":"1184_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112213","author":"F Zhao","year":"2020","unstructured":"Zhao F, Sun L, Yang N et al (2020) Increased release of microvesicles containing mitochondria is associated with the myeloid differentiation of AML-M5 leukaemia cells. Exp Cell Res. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112213","journal-title":"Exp Cell Res"},{"key":"1184_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100642","author":"E Abad","year":"2022","unstructured":"Abad E, Lyakhovich A (2022) Movement of mitochondria with mutant DNA through extracellular vesicles helps cancer cells acquire chemoresistance. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.202100642","journal-title":"ChemMedChem"},{"issue":"10","key":"1184_CR47","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.jprot.2010.06.006","volume":"73","author":"S Mathivanan","year":"2010","unstructured":"Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteome 73(10):1907\u20131920. https:\/\/doi.org\/10.1016\/j.jprot.2010.06.006","journal-title":"J Proteome"},{"issue":"6","key":"1184_CR48","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30(6):836\u2013848. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.009","journal-title":"Cancer Cell"},{"issue":"12","key":"1184_CR49","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/ni854","volume":"3","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry C, Duban L, Segura E, V\u00e9ron P, Lantz O, Amigorena S (2002) Indirect activation of na\u00efve CD4\u2009+\u2009T cells by dendritic cell-derived exosomes. Nat Immunol 3(12):1156\u20131162. https:\/\/doi.org\/10.1038\/ni854","journal-title":"Nat Immunol"},{"issue":"4","key":"1184_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/FJC.0000000000000507","volume":"70","author":"X Cui","year":"2017","unstructured":"Cui X, He Z, Liang Z, Chen Z, Wang H, Zhang J (2017) Exosomes from adipose-derived mesenchymal stem cells protect the myocardium against ischemia\/reperfusion injury through Wnt\/\u03b2-catenin signaling pathway. J Cardiovasc Pharmacol 70(4):225\u2013231. https:\/\/doi.org\/10.1097\/FJC.0000000000000507","journal-title":"J Cardiovasc Pharmacol"},{"issue":"14","key":"1184_CR51","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.18632\/oncotarget.2118","volume":"5","author":"S-B Ye","year":"2014","unstructured":"Ye S-B, Li Z-L, Luo D-H et al (2014) Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget 5(14):5439\u20135452. https:\/\/doi.org\/10.18632\/oncotarget.2118","journal-title":"Oncotarget"},{"issue":"12","key":"1184_CR52","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1073\/pnas.1017667108","volume":"108","author":"MA Antonyak","year":"2011","unstructured":"Antonyak MA, Li B, Boroughs LK et al (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A 108(12):4852\u20134857. https:\/\/doi.org\/10.1073\/pnas.1017667108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1184_CR53","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.placenta.2008.06.006","volume":"29","author":"E Pap","year":"2008","unstructured":"Pap E, P\u00e1llinger \u00c9, Falus A et al (2008) T lymphocytes are targets for platelet- and trophoblast-derived microvesicles during pregnancy. Placenta 29(9):826\u2013832. https:\/\/doi.org\/10.1016\/j.placenta.2008.06.006","journal-title":"Placenta"},{"key":"1184_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-015-0086-x","volume":"13","author":"S Raimondo","year":"2015","unstructured":"Raimondo S, Saieva L, Corrado C et al (2015) Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Commun Signal 13:8. https:\/\/doi.org\/10.1186\/s12964-015-0086-x","journal-title":"Cell Commun Signal"},{"key":"1184_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11236892","author":"A Reale","year":"2022","unstructured":"Reale A, Khong T, Spencer A (2022) Extracellular vesicles and their roles in the tumor immune microenvironment. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11236892","journal-title":"J Clin Med"},{"issue":"9","key":"1184_CR56","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/ijc.26217","volume":"130","author":"S Taverna","year":"2012","unstructured":"Taverna S, Flugy A, Saieva L et al (2012) Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer 130(9):2033\u20132043. https:\/\/doi.org\/10.1002\/ijc.26217","journal-title":"Int J Cancer"},{"issue":"5","key":"1184_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14728222.2020.1744850","volume":"24","author":"L Behrmann","year":"2020","unstructured":"Behrmann L, Wellbrock J, Fiedler W (2020) The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies. Expert Opin Ther Targets 24(5):451\u2013462. https:\/\/doi.org\/10.1080\/14728222.2020.1744850","journal-title":"Expert Opin Ther Targets"},{"issue":"6960","key":"1184_CR58","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang J, Niu C, Ye L et al (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425(6960):836\u2013841. https:\/\/doi.org\/10.1038\/nature02041","journal-title":"Nature"},{"issue":"7","key":"1184_CR59","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","volume":"121","author":"MJ Kiel","year":"2005","unstructured":"Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121(7):1109\u20131121. https:\/\/doi.org\/10.1016\/j.cell.2005.05.026","journal-title":"Cell"},{"key":"1184_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010151","author":"R Tamma","year":"2017","unstructured":"Tamma R, Ribatti D (2017) Bone niches, hematopoietic stem cells, and vessel formation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18010151","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1184_CR61","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1074\/jbc.M116.745653","volume":"292","author":"NA Goloviznina","year":"2017","unstructured":"Goloviznina NA, Verghese SC, Yoon YM, Taratula O, Marks DL, Kurre P (2017) Mesenchymal stromal cell-derived extracellular vesicles promote myeloid-biased multipotent hematopoietic progenitor expansion via toll-like receptor engagement (the Journal of Biological Chemistry (2016) 291 (24607\u201324617) DOI: 10.1074\/jbc.A116.745653). J Biol Chem 292(8):3541. https:\/\/doi.org\/10.1074\/jbc.M116.745653","journal-title":"J Biol Chem"},{"key":"1184_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121568","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, McGuinness CAS, Doherty-Boyd WS, Salmeron-Sanchez M, Donnelly H, Dalby MJ (2022) Current insights into the bone marrow niche: from biology in vivo to bioengineering ex vivo. Biomaterials. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121568","journal-title":"Biomaterials"},{"issue":"1","key":"1184_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.15283\/ijsc.2009.2.1.59","volume":"2","author":"CW Park","year":"2009","unstructured":"Park CW, Kim K-S, Bae S et al (2009) Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells 2(1):59\u201368. https:\/\/doi.org\/10.15283\/ijsc.2009.2.1.59","journal-title":"Int J Stem Cells"},{"issue":"6","key":"1184_CR64","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.18632\/oncotarget.6791","volume":"7","author":"L De Luca","year":"2016","unstructured":"De Luca L, Trino S, Laurenzana I et al (2016) MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation. Oncotarget 7(6):6676\u20136692. https:\/\/doi.org\/10.18632\/oncotarget.6791","journal-title":"Oncotarget"},{"key":"1184_CR65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.exphem.2018.05.002","volume":"64","author":"EJFM de Kruijf","year":"2018","unstructured":"de Kruijf EJFM, Zuijderduijn R, Stip MC, Fibbe WE, van Pel M (2018) Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice. Exp Hematol 64:59\u201370. https:\/\/doi.org\/10.1016\/j.exphem.2018.05.002","journal-title":"Exp Hematol"},{"key":"1184_CR66","doi-asserted-by":"publisher","unstructured":"Gong M, Yu B, Wang J et al (2017) Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget 8(28):45200-45212. https:\/\/doi.org\/10.18632\/oncotarget.16778","DOI":"10.18632\/oncotarget.16778"},{"key":"1184_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.12.021","volume":"247","author":"J Jiang","year":"2017","unstructured":"Jiang J, Kao C-Y, Papoutsakis ET (2017) How do megakaryocytic microparticles target and deliver cargo to alter the fate of hematopoietic stem cells? J Control Release 247:1\u201318. https:\/\/doi.org\/10.1016\/j.jconrel.2016.12.021","journal-title":"J Control Release"},{"key":"1184_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.3222","author":"V Niazi","year":"2022","unstructured":"Niazi V, Ghafouri-Fard S, Verdi J et al (2022) Hypoxia preconditioned mesenchymal stem cell-derived exosomes induce ex vivo expansion of umbilical cord blood hematopoietic stem cells CD133\u2009+\u2009by stimulation of Notch signaling pathway. Biotechnol Prog. https:\/\/doi.org\/10.1002\/btpr.3222","journal-title":"Biotechnol Prog"},{"issue":"8","key":"1184_CR69","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1182\/blood.V86.8.3118.3118","volume":"86","author":"C Biernaux","year":"1995","unstructured":"Biernaux C, Loos M, Sels A, Huez G, Stryckmans P (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86(8):3118\u20133122","journal-title":"Blood"},{"issue":"26","key":"1184_CR70","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J et al (2014) Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371(26):2488\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa1408617","journal-title":"N Engl J Med"},{"issue":"12","key":"1184_CR71","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie M, Lu C, Wang J et al (2014) Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 20(12):1472\u20131478. https:\/\/doi.org\/10.1038\/nm.3733","journal-title":"Nat Med"},{"issue":"7724","key":"1184_CR72","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","volume":"561","author":"H Lee-Six","year":"2018","unstructured":"Lee-Six H, \u00d8bro NF, Shepherd MS et al (2018) Population dynamics of normal human blood inferred from somatic mutations. Nature 561(7724):473\u2013478. https:\/\/doi.org\/10.1038\/s41586-018-0497-0","journal-title":"Nature"},{"issue":"5909","key":"1184_CR73","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.1164390","volume":"322","author":"A Colmone","year":"2008","unstructured":"Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA (2008) Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322(5909):1861\u20131865. https:\/\/doi.org\/10.1126\/science.1164390","journal-title":"Science"},{"issue":"1","key":"1184_CR74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","volume":"22","author":"D Duarte","year":"2018","unstructured":"Duarte D, Hawkins ED, Akinduro O et al (2018) Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell 22(1):64-77.e6. https:\/\/doi.org\/10.1016\/j.stem.2017.11.006","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1184_CR75","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers K, Pietras EM, Reynaud D et al (2013) Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13(3):285\u2013299. https:\/\/doi.org\/10.1016\/j.stem.2013.06.009","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1184_CR76","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers K, Pietras EM, Reynaud D et al (2013) Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13(3):285\u2013299. https:\/\/doi.org\/10.1016\/j.stem.2013.06.009","journal-title":"Cell Stem Cell"},{"issue":"5909","key":"1184_CR77","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.1164390","volume":"322","author":"A Colmone","year":"2008","unstructured":"Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA (2008) Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322(5909):1861\u20131865. https:\/\/doi.org\/10.1126\/science.1164390","journal-title":"Science"},{"issue":"1","key":"1184_CR78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","volume":"22","author":"D Duarte","year":"2018","unstructured":"Duarte D, Hawkins ED, Akinduro O et al (2018) Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell 22(1):64-77.e6. https:\/\/doi.org\/10.1016\/j.stem.2017.11.006","journal-title":"Cell Stem Cell"},{"issue":"3","key":"1184_CR79","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/leu.2017.259","volume":"32","author":"B Kumar","year":"2018","unstructured":"Kumar B, Garcia M, Weng L et al (2018) Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia 32(3):575\u2013587. https:\/\/doi.org\/10.1038\/leu.2017.259","journal-title":"Leukemia"},{"issue":"19","key":"1184_CR80","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.7150\/thno.34813","volume":"9","author":"X Gao","year":"2019","unstructured":"Gao X, Wan Z, Wei M et al (2019) Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320. Theranostics 9(19):5642\u20135656. https:\/\/doi.org\/10.7150\/thno.34813","journal-title":"Theranostics"},{"issue":"444","key":"1184_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf2797","volume":"9","author":"NI Hornick","year":"2016","unstructured":"Hornick NI, Doron B, Abdelhamed S et al (2016) AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB. Sci Signal 9(444):ra88. https:\/\/doi.org\/10.1126\/scisignal.aaf2797","journal-title":"Sci Signal"},{"issue":"3","key":"1184_CR82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","volume":"45","author":"CB Lozzio","year":"1975","unstructured":"Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45(3):321\u2013334","journal-title":"Blood"},{"issue":"8","key":"1184_CR83","first-page":"822","volume":"15","author":"D Seigneurin","year":"1987","unstructured":"Seigneurin D, Champelovier P, Mouchiroud G et al (1987) Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics. Exp Hematol 15(8):822\u2013832","journal-title":"Exp Hematol"},{"key":"1184_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.584232","volume":"8","author":"A Adamo","year":"2020","unstructured":"Adamo A, Delfino P, Gatti A et al (2020) HS-5 and HS-27A stromal cell lines to study bone marrow mesenchymal stromal cell-mediated support to cancer development. Front Cell Dev Biol 8:584232. https:\/\/doi.org\/10.3389\/fcell.2020.584232","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1184_CR85","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","volume":"85","author":"BA Roecklein","year":"1995","unstructured":"Roecklein BA, Torok-Storb B (1995) Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes. Blood 85(4):997\u20131005","journal-title":"Blood"},{"issue":"11","key":"1184_CR86","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52(11):2745\u20132756. https:\/\/doi.org\/10.1172\/JCI107470","journal-title":"J Clin Invest"},{"issue":"20","key":"1184_CR87","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1073\/pnas.81.20.6413","volume":"81","author":"H Hoshi","year":"1984","unstructured":"Hoshi H, McKeehan WL (1984) Brain- and liver cell-derived factors are required for growth of human endothelial cells in serum-free culture. Proc Natl Acad Sci U S A 81(20):6413\u20136417. https:\/\/doi.org\/10.1073\/pnas.81.20.6413","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1184_CR88","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s40778-016-0066-0","volume":"2","author":"J-P Levesque","year":"2016","unstructured":"Levesque J-P, Winkler IG (2016) Cell adhesion molecules in normal and malignant hematopoiesis: from bench to bedside. Curr Stem Cell Rep 2(4):356\u2013367. https:\/\/doi.org\/10.1007\/s40778-016-0066-0","journal-title":"Curr Stem Cell Rep"},{"issue":"1\u20132","key":"1184_CR89","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","volume":"348","author":"C Corrado","year":"2014","unstructured":"Corrado C, Raimondo S, Saieva L, Flugy AM, De Leo G, Alessandro R (2014) Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett 348(1\u20132):71\u201376. https:\/\/doi.org\/10.1016\/j.canlet.2014.03.009","journal-title":"Cancer Lett"},{"issue":"10","key":"1184_CR90","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/jcmm.12873","volume":"20","author":"C Corrado","year":"2016","unstructured":"Corrado C, Saieva L, Raimondo S, Santoro A, De Leo G, Alessandro R (2016) Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med 20(10):1829\u20131839. https:\/\/doi.org\/10.1111\/jcmm.12873","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1184_CR91","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2019.10.096","volume":"521","author":"Y-H Jiang","year":"2020","unstructured":"Jiang Y-H, Liu J, Lin J et al (2020) K562 cell-derived exosomes suppress the adhesive function of bone marrow mesenchymal stem cells via delivery of miR-711. Biochem Biophys Res Commun 521(3):584\u2013589. https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.096","journal-title":"Biochem Biophys Res Commun"},{"key":"1184_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-169","volume":"13","author":"S Taverna","year":"2014","unstructured":"Taverna S, Amodeo V, Saieva L et al (2014) Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells. Mol Cancer 13:169. https:\/\/doi.org\/10.1186\/1476-4598-13-169","journal-title":"Mol Cancer"},{"issue":"12","key":"1184_CR93","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.7314\/APJCP.2013.14.12.7501","volume":"14","author":"D-Q Feng","year":"2013","unstructured":"Feng D-Q, Huang B, Li J et al (2013) Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes. Asian Pac J Cancer Prev 14(12):7501\u20137508","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"1184_CR94","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nm.4499","volume":"24","author":"B Zhang","year":"2018","unstructured":"Zhang B, Nguyen LXT, Li L et al (2018) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med 24(4):450\u2013462. https:\/\/doi.org\/10.1038\/nm.4499","journal-title":"Nat Med"},{"issue":"6960","key":"1184_CR95","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425(6960):841\u2013846. https:\/\/doi.org\/10.1038\/nature02040","journal-title":"Nature"},{"issue":"17","key":"1184_CR96","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1182\/blood-2014-06-582924","volume":"125","author":"M Bowers","year":"2015","unstructured":"Bowers M, Zhang B, Ho Y, Agarwal P, Chen C-C, Bhatia R (2015) Osteoblast ablation reduces normal long-term hematopoietic stem cell self-renewal but accelerates leukemia development. Blood 125(17):2678\u20132688. https:\/\/doi.org\/10.1182\/blood-2014-06-582924","journal-title":"Blood"},{"issue":"19","key":"1184_CR97","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.7150\/thno.34813","volume":"9","author":"X Gao","year":"2019","unstructured":"Gao X, Wan Z, Wei M et al (2019) Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320. Theranostics 9(19):5642\u20135656. https:\/\/doi.org\/10.7150\/thno.34813","journal-title":"Theranostics"},{"issue":"12","key":"1184_CR98","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.exphem.2004.09.001","volume":"32","author":"W Li","year":"2004","unstructured":"Li W, Johnson SA, Shelley WC, Yoder MC (2004) Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp Hematol 32(12):1226\u20131237. https:\/\/doi.org\/10.1016\/j.exphem.2004.09.001","journal-title":"Exp Hematol"},{"issue":"4","key":"1184_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060823","volume":"8","author":"B Pezeshkian","year":"2013","unstructured":"Pezeshkian B, Donnelly C, Tamburo K, Geddes T, Madlambayan GJ (2013) Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism. PLoS One 8(4):e60823. https:\/\/doi.org\/10.1371\/journal.pone.0060823","journal-title":"PLoS One"},{"issue":"1","key":"1184_CR100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10456-011-9241-1","volume":"15","author":"M Mineo","year":"2012","unstructured":"Mineo M, Garfield SH, Taverna S et al (2012) Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis 15(1):33\u201345. https:\/\/doi.org\/10.1007\/s10456-011-9241-1","journal-title":"Angiogenesis"},{"issue":"22","key":"1184_CR101","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/onc.2012.295","volume":"32","author":"T Umezu","year":"2013","unstructured":"Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH (2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32(22):2747\u20132755. https:\/\/doi.org\/10.1038\/onc.2012.295","journal-title":"Oncogene"},{"issue":"22","key":"1184_CR102","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/onc.2012.295","volume":"32","author":"T Umezu","year":"2013","unstructured":"Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH (2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32(22):2747\u20132755. https:\/\/doi.org\/10.1038\/onc.2012.295","journal-title":"Oncogene"},{"issue":"48","key":"1184_CR103","doi-asserted-by":"publisher","first-page":"34343","DOI":"10.1074\/jbc.M113.480822","volume":"288","author":"H Tadokoro","year":"2013","unstructured":"Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki JH (2013) Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem 288(48):34343\u201334351. https:\/\/doi.org\/10.1074\/jbc.M113.480822","journal-title":"J Biol Chem"},{"issue":"23","key":"1184_CR104","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1074\/jbc.M800731200","volume":"283","author":"P Fasanaro","year":"2008","unstructured":"Fasanaro P, D\u2019Alessandra Y, Di Stefano V et al (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283(23):15878\u201315883. https:\/\/doi.org\/10.1074\/jbc.M800731200","journal-title":"J Biol Chem"},{"issue":"1","key":"1184_CR105","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jcrt.JCRT_1017_20","volume":"18","author":"AK Karaboga Arslan","year":"2022","unstructured":"Karaboga Arslan AK, Uzunhisarc\u0131kl\u0131 E, Yerer MB, Bishayee A (2022) The golden spice curcumin in cancer: a perspective on finalized clinical trials during the last 10 years. J Cancer Res Ther 18(1):19\u201326. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1017_20","journal-title":"J Cancer Res Ther"},{"issue":"21","key":"1184_CR106","doi-asserted-by":"publisher","first-page":"30420","DOI":"10.18632\/oncotarget.8483","volume":"7","author":"S Taverna","year":"2016","unstructured":"Taverna S, Fontana S, Monteleone F et al (2016) Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype via exosomal miR-21. Oncotarget 7(21):30420\u201330439. https:\/\/doi.org\/10.18632\/oncotarget.8483","journal-title":"Oncotarget"},{"key":"1184_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061203","author":"J Swatler","year":"2021","unstructured":"Swatler J, Turos-Korgul L, Kozlowska E, Piwocka K (2021) Immunosuppressive cell subsets and factors in myeloid leukemias. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13061203","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1184_CR108","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/jcmm.13326","volume":"22","author":"C Giallongo","year":"2018","unstructured":"Giallongo C, Parrinello NL, La Cava P et al (2018) Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib. J Cell Mol Med 22(2):1070\u20131080. https:\/\/doi.org\/10.1111\/jcmm.13326","journal-title":"J Cell Mol Med"},{"issue":"16","key":"1184_CR109","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","volume":"185","author":"JO Lundberg","year":"2022","unstructured":"Lundberg JO, Weitzberg E (2022) Nitric oxide signaling in health and disease. Cell 185(16):2853\u20132878. https:\/\/doi.org\/10.1016\/j.cell.2022.06.010","journal-title":"Cell"},{"issue":"21","key":"1184_CR110","doi-asserted-by":"publisher","first-page":"15941","DOI":"10.1021\/acs.inorgchem.1c02434","volume":"60","author":"KM Miranda","year":"2021","unstructured":"Miranda KM, Ridnour LA, McGinity CL, Bhattacharyya D, Wink DA (2021) Nitric oxide and cancer: when to give and when to take away? Inorg Chem 60(21):15941\u201315947. https:\/\/doi.org\/10.1021\/acs.inorgchem.1c02434","journal-title":"Inorg Chem"},{"issue":"5","key":"1184_CR111","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF (2016) Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev 30(5):489\u2013501. https:\/\/doi.org\/10.1101\/gad.276733.115","journal-title":"Genes Dev"},{"key":"1184_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108765","volume":"114","author":"Z Si","year":"2019","unstructured":"Si Z, Wang X, Sun C et al (2019) Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother 114:108765. https:\/\/doi.org\/10.1016\/j.biopha.2019.108765","journal-title":"Biomed Pharmacother"},{"key":"1184_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.649552","volume":"9","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Li X, Wang F et al (2021) Emerging Potential of Exosomes on Adipogenic Differentiation of Mesenchymal Stem Cells. Front Cell Dev Biol 9:649552. https:\/\/doi.org\/10.3389\/fcell.2021.649552","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"1184_CR114","doi-asserted-by":"publisher","first-page":"21274","DOI":"10.1002\/jcp.28732","volume":"234","author":"Z Wan","year":"2019","unstructured":"Wan Z, Chen X, Gao X et al (2019) Chronic myeloid leukemia-derived exosomes attenuate adipogenesis of adipose derived mesenchymal stem cells via transporting miR-92a-3p. J Cell Physiol 234(11):21274\u201321283. https:\/\/doi.org\/10.1002\/jcp.28732","journal-title":"J Cell Physiol"},{"issue":"6","key":"1184_CR115","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10(6):415\u2013424. https:\/\/doi.org\/10.1038\/nrc2853","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"1184_CR116","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJJ Waugh","year":"2008","unstructured":"Waugh DJJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14(21):6735\u20136741. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4843","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1184_CR117","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier S, Gouwy M, Proost P (2023) The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol 20(3):217\u2013251. https:\/\/doi.org\/10.1038\/s41423-023-00974-6","journal-title":"Cell Mol Immunol"},{"issue":"1\u20132","key":"1184_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","volume":"348","author":"C Corrado","year":"2014","unstructured":"Corrado C, Raimondo S, Saieva L, Flugy AM, De Leo G, Alessandro R (2014) Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. Cancer Lett 348(1\u20132):71\u201376. https:\/\/doi.org\/10.1016\/j.canlet.2014.03.009","journal-title":"Cancer Lett"},{"issue":"19","key":"1184_CR119","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.7150\/thno.34813","volume":"9","author":"X Gao","year":"2019","unstructured":"Gao X, Wan Z, Wei M et al (2019) Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320. Theranostics 9(19):5642\u20135656. https:\/\/doi.org\/10.7150\/thno.34813","journal-title":"Theranostics"},{"key":"1184_CR120","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8890201","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang X, Yang Y, Yang Y, Chen H, Tu H, Li J (2020) Exosomes from bone marrow microenvironment-derived mesenchymal stem cells affect CML cells growth and promote drug resistance to tyrosine kinase inhibitors. Stem Cells Int 2020:8890201. https:\/\/doi.org\/10.1155\/2020\/8890201","journal-title":"Stem Cells Int"},{"issue":"8","key":"1184_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105200","volume":"9","author":"J Cai","year":"2014","unstructured":"Cai J, Wu G, Tan X et al (2014) Transferred BCR\/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice. PLoS One 9(8):e105200. https:\/\/doi.org\/10.1371\/journal.pone.0105200","journal-title":"PLoS One"},{"issue":"4","key":"1184_CR122","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/jmcb\/mjt011","volume":"5","author":"J Cai","year":"2013","unstructured":"Cai J, Han Y, Ren H et al (2013) Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol 5(4):227\u2013238. https:\/\/doi.org\/10.1093\/jmcb\/mjt011","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"1184_CR123","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3892\/ijo.2020.5163","volume":"58","author":"T Hrdinova","year":"2021","unstructured":"Hrdinova T, Toman O, Dresler J et al (2021) Exosomes released by imatinib-resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib-sensitive cells in the presence of imatinib. Int J Oncol 58(2):238\u2013250. https:\/\/doi.org\/10.3892\/ijo.2020.5163","journal-title":"Int J Oncol"},{"issue":"7","key":"1184_CR124","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.21873\/anticanres.12679","volume":"38","author":"K-W Kang","year":"2018","unstructured":"Kang K-W, Jung J-H, Hur W et al (2018) The potential of exosomes derived from chronic myelogenous leukaemia cells as a biomarker. Anticancer Res 38(7):3935\u20133942. https:\/\/doi.org\/10.21873\/anticanres.12679","journal-title":"Anticancer Res"},{"issue":"1","key":"1184_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0970-x","volume":"18","author":"TB Steinbichler","year":"2019","unstructured":"Steinbichler TB, Dudas J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova I-I (2019) Therapy resistance mediated by exosomes. Mol Cancer 18(1):58. https:\/\/doi.org\/10.1186\/s12943-019-0970-x","journal-title":"Mol Cancer"},{"issue":"8","key":"1184_CR126","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/cncr.20922","volume":"103","author":"T Lahaye","year":"2005","unstructured":"Lahaye T, Riehm B, Berger U et al (2005) Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up. Cancer 103(8):1659\u20131669. https:\/\/doi.org\/10.1002\/cncr.20922","journal-title":"Cancer"},{"issue":"2","key":"1184_CR127","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3892\/ijo.2020.5163","volume":"58","author":"T Hrdinova","year":"2021","unstructured":"Hrdinova T, Toman O, Dresler J et al (2021) Exosomes released by imatinib-resistant K562 cells contain specific membrane markers, IFITM3, CD146 and CD36 and increase the survival of imatinib-sensitive cells in the presence of imatinib. Int J Oncol 58(2):238\u2013250. https:\/\/doi.org\/10.3892\/ijo.2020.5163","journal-title":"Int J Oncol"},{"key":"1184_CR128","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2379597","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Xiao S, Huang S et al (2024) Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p\/SENP2\/PI3K\/AKT\/mTOR axis. Hematology. https:\/\/doi.org\/10.1080\/16078454.2024.2379597","journal-title":"Hematology"},{"key":"1184_CR129","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03198-1","author":"AZ Karabay","year":"2024","unstructured":"Karabay AZ, Ozkan T, Karadag Gurel A et al (2024) Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-024-03198-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"1184_CR130","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.yexcr.2017.12.001","volume":"362","author":"Q-H Min","year":"2018","unstructured":"Min Q-H, Wang X-Z, Zhang J et al (2018) Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering mir-365. Exp Cell Res 362(2):386\u2013393. https:\/\/doi.org\/10.1016\/j.yexcr.2017.12.001","journal-title":"Exp Cell Res"},{"key":"1184_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116315","author":"Z Li","year":"2024","unstructured":"Li Z, Xi Y, Tu L et al (2024) Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2024.116315","journal-title":"Biomed Pharmacother"},{"key":"1184_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1239042","volume":"13","author":"S Bernardi","year":"2023","unstructured":"Bernardi S, Mulas O, Mutti S, Costa A, Russo D, La Nasa G (2023) Extracellular vesicles in the chronic myeloid leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules. Front Oncol 13:1239042. https:\/\/doi.org\/10.3389\/fonc.2023.1239042","journal-title":"Front Oncol"},{"issue":"2","key":"1184_CR133","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1074\/mcp.M900152-MCP200","volume":"9","author":"S Mathivanan","year":"2010","unstructured":"Mathivanan S, Lim JWE, Tauro BJ, Ji H, Moritz RL, Simpson RJ (2010) Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 9(2):197\u2013208. https:\/\/doi.org\/10.1074\/mcp.M900152-MCP200","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"1184_CR134","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.3892\/ijmm.2019.4372","volume":"44","author":"S Bernardi","year":"2019","unstructured":"Bernardi S, Foroni C, Zanaglio C et al (2019) Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia. Int J Mol Med 44(6):2133\u20132144. https:\/\/doi.org\/10.3892\/ijmm.2019.4372","journal-title":"Int J Mol Med"},{"issue":"4","key":"1184_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040570","volume":"17","author":"K Ohyashiki","year":"2016","unstructured":"Ohyashiki K, Umezu T, Katagiri S et al (2016) Downregulation of plasma mir-215 in chronic myeloid leukemia patients with successful discontinuation of imatinib. Int J Mol Sci 17(4):570. https:\/\/doi.org\/10.3390\/ijms17040570","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1184_CR136","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12185-017-2199-z","volume":"105","author":"M Asano","year":"2017","unstructured":"Asano M, Umezu T, Katagiri S et al (2017) Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors. Int J Hematol 105(4):419\u2013422. https:\/\/doi.org\/10.1007\/s12185-017-2199-z","journal-title":"Int J Hematol"},{"issue":"2","key":"1184_CR137","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/hemato3020026","volume":"3","author":"T Shibuta","year":"2022","unstructured":"Shibuta T, Shimizu H, Takada Y, Fuku A, Tomiyasu S, Umemura T (2022) Mir-494 in extracellular vesicles as a potent biomarker of chronic myeloid leukemia treatment with tyrosine kinase inhibitors. Hemato 3(2):373\u2013384. https:\/\/doi.org\/10.3390\/hemato3020026","journal-title":"Hemato"},{"issue":"1","key":"1184_CR138","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-019-1002-6","volume":"18","author":"M Su","year":"2019","unstructured":"Su M, Xiao Y, Ma J et al (2019) Circular RNAs in cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Mol Cancer 18(1):90. https:\/\/doi.org\/10.1186\/s12943-019-1002-6","journal-title":"Mol Cancer"},{"key":"1184_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.728916","volume":"12","author":"A-N Zhong","year":"2021","unstructured":"Zhong A-N, Yin Y, Tang B-J et al (2021) CircRNA microarray profiling reveals hsa_circ_0058493 as a novel biomarker for Imatinib-Resistant CML. Front Pharmacol 12:728916. https:\/\/doi.org\/10.3389\/fphar.2021.728916","journal-title":"Front Pharmacol"},{"key":"1184_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012271","author":"A Rudich","year":"2022","unstructured":"Rudich A, Garzon R, Dorrance A (2022) Non-coding RNAs are implicit in chronic myeloid leukemia therapy resistance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232012271","journal-title":"Int J Mol Sci"},{"key":"1184_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.643043","author":"NK Wong","year":"2021","unstructured":"Wong NK, Luo S, Chow EYD et al (2021) The tyrosine kinase-driven networks of novel long non-coding RNAs and their molecular targets in myeloproliferative neoplasms. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.643043","journal-title":"Front Cell Dev Biol"},{"key":"1184_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.779567","volume":"11","author":"M-Y Li","year":"2021","unstructured":"Li M-Y, Zhao C, Chen L et al (2021) Quantitative proteomic analysis of plasma exosomes to identify the candidate biomarker of Imatinib resistance in chronic myeloid leukemia patients. Front Oncol 11:779567. https:\/\/doi.org\/10.3389\/fonc.2021.779567","journal-title":"Front Oncol"},{"issue":"5","key":"1184_CR143","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.7150\/thno.17092","volume":"7","author":"D Bellavia","year":"2017","unstructured":"Bellavia D, Raimondo S, Calabrese G et al (2017) Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. Theranostics 7(5):1333\u20131345. https:\/\/doi.org\/10.7150\/thno.17092","journal-title":"Theranostics"},{"issue":"23\u201324","key":"1184_CR144","doi-asserted-by":"publisher","first-page":"9569","DOI":"10.1007\/s00253-019-10127-3","volume":"103","author":"Y Dong","year":"2019","unstructured":"Dong Y, Lin Y, Gao X et al (2019) Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib. Appl Microbiol Biotechnol 103(23\u201324):9569\u20139582. https:\/\/doi.org\/10.1007\/s00253-019-10127-3","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"1184_CR145","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.biochi.2013.07.015","volume":"95","author":"H Kupcova Skalnikova","year":"2013","unstructured":"Kupcova Skalnikova H (2013) Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95(12):2196\u20132211. https:\/\/doi.org\/10.1016\/j.biochi.2013.07.015","journal-title":"Biochimie"},{"key":"1184_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122542","volume":"342","author":"H Padinharayil","year":"2024","unstructured":"Padinharayil H, Varghese J, Wilson C, George A (2024) Mesenchymal stem cell-derived exosomes: characteristics and applications in disease pathology and management. Life Sci 342:122542. https:\/\/doi.org\/10.1016\/j.lfs.2024.122542","journal-title":"Life Sci"},{"issue":"4","key":"1184_CR147","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s12079-023-00794-3","volume":"17","author":"B Jahangiri","year":"2023","unstructured":"Jahangiri B, Khalaj-Kondori M, Asadollahi E, Kian Saei A, Sadeghizadeh M (2023) Dual impacts of mesenchymal stem cell-derived exosomes on cancer cells: unravelling complex interactions. J Cell Commun Signal 17(4):1229\u20131247. https:\/\/doi.org\/10.1007\/s12079-023-00794-3","journal-title":"J Cell Commun Signal"},{"issue":"2","key":"1184_CR148","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcyt.2017.11.006","volume":"20","author":"Y Liu","year":"2018","unstructured":"Liu Y, Song B, Wei Y et al (2018) Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway. Cytotherapy 20(2):181\u2013188. https:\/\/doi.org\/10.1016\/j.jcyt.2017.11.006","journal-title":"Cytotherapy"},{"issue":"1","key":"1184_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04531-3","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Chen Y, Zhang M et al (2022) HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p\/USP6\/GLS1 axis. Cell Death Dis 13(1):92. https:\/\/doi.org\/10.1038\/s41419-022-04531-3","journal-title":"Cell Death Dis"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01184-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:16:50Z","timestamp":1781648210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01184-0","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}